Alembic Pharmaceuticals Ltd logo

Alembic Pharmaceuticals Ltd Dividend History

Last updated: |
NSE: APLLTD|
Stock price: ₹810.95|
Share price & overview ↗

Latest Dividend

₹12.00

FY2026 · Final

Declared On

15/05/2026

announcement date

Ex-Date

29/07/2026

last ex-dividend date

Record Date

29/07/2026

eligibility cutoff

Dividend Yield

1.48%

as of 11 Sep 2026

History of Alembic Pharmaceuticals Ltd's Dividend payments

Announcement DateEx-DateRecord DateTypeDividend / Share
15/05/2026
29/07/2026
29/07/2026
Final
₹12.00
06/05/2025
29/07/2025
29/07/2025
Final
₹11.00
09/05/2024
15/07/2024
15/07/2024
Final
₹11.00
05/05/2023
28/07/2023
28/07/2023
Final
₹8.00
02/05/2022
17/08/2022
18/08/2022
Interim
₹10.00
View More

FAQs

What is the latest dividend declared by Alembic Pharmaceuticals Ltd?

Alembic Pharmaceuticals Ltd declared a dividend of ₹12.00 per share on 15 May 2026, with a record date of 29 Jul 2026.

When will I receive the Alembic Pharmaceuticals Ltd dividend?

To receive the Alembic Pharmaceuticals Ltd dividend, you must hold APLLTD shares before the ex-date of 29 Jul 2026. Under T+1 settlement, buying on the ex-date itself makes you ineligible. The dividend is credited to your linked bank account within 30 days of the record date.

How often does Alembic Pharmaceuticals Ltd pay dividend?

Alembic Pharmaceuticals Ltd pays one dividend per financial year, typically declared after Q4 board meeting results.

Is Alembic Pharmaceuticals Ltd a good stock for dividend income?

Alembic Pharmaceuticals Ltd's current dividend yield is 1.48%, making it a consistent dividend-paying stock.

How much tax will I pay on Alembic Pharmaceuticals Ltd dividend?

Dividends from Alembic Pharmaceuticals Ltd are taxable as income from other sources at your applicable income tax slab rate. TDS at 10% is deducted at source if your total dividend income from Alembic Pharmaceuticals Ltd exceeds ₹10,000 in a financial year. NRI investors are subject to 20% TDS or applicable DTAA rate. You can claim TDS credit when filing your ITR.